{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "71860-102",
      "generic_name": "olezarsen sodium",
      "labeler_name": "Ionis Pharmaceuticals, Inc.",
      "brand_name": "TRYNGOLZA",
      "active_ingredients": [
        {
          "name": "OLEZARSEN SODIUM",
          "strength": "50 mg/.8mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "71860-102-01",
          "description": "1 SYRINGE, GLASS in 1 CARTON (71860-102-01)  / .8 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20260624",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Ionis Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "2701422",
          "2701428",
          "2746496",
          "2746499"
        ],
        "spl_set_id": [
          "0f51aa8e-8475-8cf9-e063-6394a90a6848"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "NSY2BY6PSB"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "55b4730e-4610-c0f2-e063-6294a90a90ae",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20260624",
      "product_id": "71860-102_55b4730e-4610-c0f2-e063-6294a90a90ae",
      "application_number": "NDA218614",
      "brand_name_base": "TRYNGOLZA",
      "pharm_class": [
        "APOC-III-directed RNA Interaction [EPC]",
        "Antisense Oligonucleotide [EPC]",
        "Antisense [CS]",
        "Increased RNA Degradation [PE]"
      ]
    }
  ]
}